{
  "version": "1.0",
  "type": "link",
  "title": "Pharma & Biotech CFO Clinical/Regulatory Agent Semivariance & Stage-Gating × CASE-02 (FP&A, PROCUREMENT & AP INVOICE FINOPS (CASCADE ROUTING)) — CFO AI Benchmark | MARKOWITZ.SYSTEMS",
  "description": "Pharma & Biotech CFO Clinical/Regulatory Agent Semivariance & Stage-Gating (GxP / 21 CFR Part 11 / R&D Stage-Gate) benchmarked with CASE-02 ($1.9B B2B SaaS & Cloud Enterprise · 1.8M Monthly AP, Contract & Variance Queries): Capping unconstrained retry loops at K ≤ 2 and routing by calibrated difficulty preserved frontier quality on complex contracts while returning $1.26M/yr directly to EBITDA.",
  "author_name": "MARKOWITZ.SYSTEMS Quantitative Finance & Continuing Professional Education Collective",
  "author_url": "https://markowitz.systems/education",
  "provider_name": "MARKOWITZ.SYSTEMS — Fresh AI Preprints & Professional Upskilling",
  "provider_url": "https://markowitz.systems",
  "cache_age": 86400,
  "thumbnail_url": "https://markowitz.systems/og-card.png",
  "thumbnail_width": 1200,
  "thumbnail_height": 630,
  "url": "https://markowitz.systems/cfo-pharma-biotech-rd/case-02",
  "fresh_preprints_url": "https://markowitz.systems/preprints",
  "continuing_education_url": "https://markowitz.systems/education",
  "meta_education_url": "https://markowitz.systems/meta-education"
}